← back to search

Erik N. Bergstrom

Natera (United States) · US
Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Cancer Genomics and Diagnostics, Genetic factors in colorectal cancer, DNA Repair Mechanisms, and Genetics and Neurodevelopmental Disorders.
h-index
39
citations
24,172
works
137
NIH funding
primary concept
Biology
email

Recent publications

Geographic and age variations in mutational processes in colorectal cancer
Nature 2025cited by 107position: middledoi
The mutagenic forces shaping the genomes of lung cancer in never smokers
Nature 2025cited by 32position: middledoi
The complexity of tobacco smoke-induced mutagenesis in head and neck cancer
Nature Genetics 2025cited by 16position: middledoi
Long-Term Latency of Highly Mutated Cells in Normal Mouse Skin Is Reversed by Exposure to Tumor Promoters and Chronic Tissue Damage
Cancer Discovery 2025cited by 11position: middledoi
APOBEC affects tumor evolution and age at onset of lung cancer in smokers
Nature Communications 2025cited by 7position: middledoi
HRProfiler Detects Homologous Recombination Deficiency in Breast and Ovarian Cancers Using Whole-Genome and Whole-Exome Sequencing Data
Cancer Research 2025cited by 6position: middledoi
Geographic variation of mutagenic exposures in kidney cancer genomes
Nature 2024cited by 73position: middledoi
Deep Learning Artificial Intelligence Predicts Homologous Recombination Deficiency and Platinum Response From Histologic Slides
Journal of Clinical Oncology 2024cited by 62position: firstdoi
Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity
Nature Genetics 2023cited by 82position: middledoi
APOBEC3B regulates R-loops and promotes transcription-associated mutagenesis in cancer
Nature Genetics 2023cited by 77position: middledoi
Topography of mutational signatures in human cancer
Cell Reports 2023cited by 44position: middledoi
Visualizing and exploring patterns of large mutational events with SigProfilerMatrixGenerator
BMC Genomics 2023cited by 23position: middledoi
Author Correction: Pan-cancer analysis of whole genomes
Nature 2023cited by 13position: middledoi
Author Correction: The repertoire of mutational signatures in human cancer
Nature 2023cited by 9position: middledoi
Author Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers
Nature Genetics 2023cited by 2position: middledoi
Uncovering novel mutational signatures by de novo extraction with SigProfilerExtractor
Cell Genomics 2022cited by 356position: middledoi
Mechanisms of APOBEC3 mutagenesis in human cancer cells
Nature 2022cited by 253position: middledoi
Mapping clustered mutations in cancer reveals APOBEC3 mutagenesis of ecDNA
Nature 2022cited by 163position: firstdoi
Author Correction: Divergent mutational processes distinguish hypoxic and normoxic tumours
Nature Communications 2022cited by 1position: middledoi
Mutational signatures in esophageal squamous cell carcinoma from eight countries with varying incidence
Nature Genetics 2021cited by 197position: middledoi
The repertoire of mutational signatures in human cancer
Nature 2020cited by 3,686position: middledoi
Pan-cancer analysis of whole genomes
Nature 2020cited by 3,258position: middledoi
Comprehensive molecular characterization of mitochondrial genomes in human cancers
Nature Genetics 2020cited by 507position: middledoi
Divergent mutational processes distinguish hypoxic and normoxic tumours
Nature Communications 2020cited by 142position: middledoi
SigProfilerMatrixGenerator: a tool for visualizing and exploring patterns of small mutational events
BMC Genomics 2019cited by 344position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Ludmil B. Alexandrov · Leiden University Medical Center9 papers (2019–2025)Mark Barnes · University of California San Diego4 papers (2019–2023)Christopher D. Steele · University of California San Diego Medical Center3 papers (2022–2025)Ammal Abbasi · University of California San Diego3 papers (2023–2025)Azhar Khandekar · Fred Hutch Cancer Center3 papers (2022–2025)Marcos Díaz‐Gay · University of California San Diego3 papers (2023–2024)Nischalan Pillay · University of Otago3 papers (2022–2025)Reuben S. Harris · Howard Hughes Medical Institute2 papers (2022–2023)Michael R. Stratton · Colon and Rectal Surgery Associates2 papers (2019–2022)Mia Petljak · New York University2 papers (2022–2022)Burçak Otlu · Middle East Technical University1 papers (2023–2023)Paul S. Mischel · Stanford Health Care1 papers (2022–2022)Olga K. Mirzoeva · University of California, San Francisco1 papers (2025–2025) · 1 papers (2025–2025)Kyle Halliwill · AbbVie (United States)1 papers (2025–2025)S. M. Ashiqul Islam · Albany State University1 papers (2025–2025) · 1 papers (2022–2022)Bojana Stefanovska · Howard Hughes Medical Institute1 papers (2023–2023)Allan Balmain · UCSF Helen Diller Family Comprehensive Cancer Center1 papers (2025–2025)Matthew C. Jarvis · University of Minnesota1 papers (2023–2023)